BPG is committed to discovery and dissemination of knowledge
Citation
Syed N, Chintakuntlawar AV, Vilasini D, Al Salami AM, Al Hasan R, Afrooz I, Uttam Chandani K, Chandani AU, Chehal A. Low testing rates and high BRCA prevalence: Poly (ADP-ribose) polymerase inhibitor use in Middle East BRCA/homologous recombination deficiency-positive cancer patients. World J Clin Oncol 2024; 15(7): 848-858 [PMID: 39071455 DOI: 10.5306/wjco.v15.i7.848]
Please LOGIN to submit a new comment.